NCT04050254

Brief Summary

The purpose of this study is to assess the effects on pain of transcranial direct current stimulation combined with therapeutic exercise in fibromyalgia patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 8, 2019

Completed
25 days until next milestone

Study Start

First participant enrolled

September 2, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 27, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 27, 2020

Completed
Last Updated

June 11, 2021

Status Verified

June 1, 2021

Enrollment Period

7 months

First QC Date

June 14, 2019

Last Update Submit

June 10, 2021

Conditions

Keywords

tDCSTherapeutic exerciseReferred painCentral sensitization

Outcome Measures

Primary Outcomes (2)

  • Change in referred pain area after suprathreshold pressure stimulation from baseline to post-treatment

    A pressure algometer (Force Ten™, Wagner Instruments, USA) will be used. It will be performed on the infraspinatus muscle (point equidistant between the midpoint of the spine of the scapula, the inferior angle of the scapula and the midpoint of the medial border of the scapula) at a constant suprathreshold pressure (20% above the pressure pain threshold) for 60 seconds. After the stimulation, the subject should draw the induced pain area on a digital bodychart using the Navigate Pain application (Navigate Pain, Aalborg University, Denmark).

    Baseline; immediately after intervention; 1-month after intervention

  • Change in pain intensity from baseline to post-treatment

    It will be measured with a visual analog scale (VAS) of 100 millimeters in length. The subject has to indicate the level of pain he feels, being 0 the absence of pain and 100 the maximum imaginable

    Baseline; immediately after intervention; 1-month after intervention

Secondary Outcomes (4)

  • Fibromyalgia Impact Quality-of-Life

    Baseline; immediately after intervention; 1-month after intervention

  • Anxiety

    Baseline; immediately after intervention; 1-month after intervention

  • Pain catastrophizing

    Baseline; immediately after intervention; 1-month after intervention

  • Depression

    Baseline; immediately after intervention; 1-month after intervention

Other Outcomes (1)

  • Blinding

    Immediately after intervention

Study Arms (3)

Real tDCS + exercise

EXPERIMENTAL

Transcranial direct current stimulation combined with therapeutic exercise

Device: Real tDCSDevice: Therapeutic exercise

Sham tDCS + exercise

SHAM COMPARATOR

Sham transcranial direct current stimulation combined with therapeutic exercise

Device: Sham tDCSDevice: Therapeutic exercise

Control

NO INTERVENTION

No treatment.

Interventions

Real tDCSDEVICE

Real tDCS (STARTSTIM® 8 stimulator, Neuroelectric Barcelona, Spain) for five sessions on alternate days.tDCS is a galvanic current applied by a cap for 20 minutes at an intensity of 2 milliamps.

Real tDCS + exercise
Sham tDCSDEVICE

Sham current (STARSTIM® 8 stimulator, Neuroelectric Barcelona, Spain) for five sessions on alternate days. Sham tDCS will be applied for the same time than real tDCS.

Sham tDCS + exercise

The therapeutic exercise program will include aerobic exercise and muscle strengthening for five sessions on alternate days. The program will include exercises and will last 30-45 minutes.

Real tDCS + exerciseSham tDCS + exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years.
  • Fulfilled the 2010 American Colleague of Rheumatology criteria for fibromyalgia.
  • Normal pain intensity of 4 or more points on a visual analog scale.
  • Able to participated in a therapeutic exercise program.
  • Understanding of spoken and written Spanish.

You may not qualify if:

  • Pregnancy or breastfeeding.
  • Metallic implants in the head.
  • Tumor, trauma or surgery in the brain.
  • Epilepsy or stroke.
  • History of substance abuse in the last 6 months.
  • Use of carbamazepine in the last 6 months.
  • Severe depression (Beck Depression Index II of 29 or more).
  • Diagnosed psychiatric pathology.
  • Rheumatic pathology not medically controlled.
  • Coexisting autoimmune pathology.
  • Chronic inflammatory disease (rheumatoid arthritis, erythematosus systemic lupus, inflammatory bowel disease).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital General Nuestra Señora del Prado

Talavera de la Reina, Toledo, 45600, Spain

Location

Related Publications (1)

  • Arroyo-Fernandez R, Avendano-Coy J, Velasco-Velasco R, Palomo-Carrion R, Bravo-Esteban E, Ferri-Morales A. Effectiveness of Transcranial Direct Current Stimulation Combined With Exercising in People With Fibromyalgia: A Randomized Sham-Controlled Clinical Trial. Arch Phys Med Rehabil. 2022 Aug;103(8):1524-1532. doi: 10.1016/j.apmr.2022.02.020. Epub 2022 Mar 22.

MeSH Terms

Conditions

FibromyalgiaPain, Referred

Interventions

Exercise Therapy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2019

First Posted

August 8, 2019

Study Start

September 2, 2019

Primary Completion

March 27, 2020

Study Completion

March 27, 2020

Last Updated

June 11, 2021

Record last verified: 2021-06

Locations